INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness ...
Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.
Wenzhou Medical University and collaborating institutions have identified a population of human neural retinal stem-like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback